What is the Impact Factor of Sarcoidosis Vasculitis and Diffuse Lung Diseases?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Sarcoidosis Vasculitis and Diffuse Lung Diseases is 1.80, ranking in quartile Q3 of Web of Science (SCIE).

Is Sarcoidosis Vasculitis and Diffuse Lung Diseases indexed in Web of Science or Scopus?

Yes, Sarcoidosis Vasculitis and Diffuse Lung Diseases is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.500 (Q3) and an H-index of 68.

Who publishes Sarcoidosis Vasculitis and Diffuse Lung Diseases and what is the Article Processing Charge (APC)?

Sarcoidosis Vasculitis and Diffuse Lung Diseases is published by Mattioli 1885 S.p.A.. The estimated Article Processing Charge (APC) is approximately $2,854 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The official ISO-4 abbreviation of Sarcoidosis Vasculitis and Diffuse Lung Diseases is "SARCOIDOSIS VASC DIF". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q3SCImago #11,896Subscription

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Abbreviation (ISO):SARCOIDOSIS VASC DIF

•

Identifier (ISSN):1124-0490(Print)/2532-179X(Online)

•

Publisher:Mattioli 1885 S.p.A.

Official Website Submission Portal Compare

Clarivate IF (2026)

1.8– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Sarcoidosis Vasculitis and Diffuse Lung Diseases

WoS Q3

Annual Impact Factor Metric

Current (2026):1.8

Scopus SJR & RankScopus Q3

0.5

#11,896

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

68 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate14.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessSubscription

41articles/year

0% Gold OA•73.53% Original Research

Aims & Scope

Sarcoidosis Vasculitis and Diffuse Lung Disease is a quarterly journal founded in 1984 by G. Rizzato. Now directed by R. Baughman (Cincinnati), P. Rottoli (Siena) and S. Tomassetti (Forlì), is the oldest and most prestigious Italian journal in such field.

Topics Covered (Recognized by AI)

MedicineInternal medicine97.3%Pathology90.6%Biology76.5%Dermatology63%Sarcoidosis59.7%Philosophy50.8%Linguistics49.6%Lung47.8%Immunology47.1%Surgery45.1%Radiology41.8%Genetics38%Psychology36.3%Psychiatry31.9%Disease30.7%Chemistry30.5%Biochemistry26.5%Gastroenterology21.1%Mathematics21.1%

Primary Research Areas

Medicine Respiratory System

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

RESPIRATORY SYSTEM

Rank77/107

IndexSCIE

JCISCIE2026

RESPIRATORY SYSTEM

Rank83/107

IndexSCIE

Category	Index	Rank	Quartile
RESPIRATORY SYSTEM	JCRSCIE	77/107	Q3
RESPIRATORY SYSTEM	JCISCIE	83/107	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

14 year

2026Latest

IF1.8

Articles / Year—

Total Citations—

2025

IF1.8

Articles / Year—

Total Citations—

2024

IF1.4

Articles / Year—

Total Citations—

2023

IF1.6

Articles / Year—

Total Citations—

2022

IF1.803

Articles / Year—

Total Citations—

Year	Impact Factor	Articles / Year	Total Citations
2026	1.8	—	—
2025	1.8	—	—
2024	1.4	—	—
2023	1.6	—	—
2022	1.803	—	—
2021	0.67	—	—
2020	0.362	—	—
2019	0.889	—	—
2018	1.267	—	—
2014	—	1	1
2010	—	1	0
2006	—	1	0
2005	—	1	12
2004	—	1	0

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,896Scopus Q3SCImago Profile

Scopus Coverage:1996-2025

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q3

0.5

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.43

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,854 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations218

3-Year Documents148

Citable Documents127

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Immunology and AllergyQ3

Internal MedicineQ3

Medicine (miscellaneous)Q3

Pulmonary and Respiratory MedicineQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 14.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区RESPIRATORY SYSTEM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Sarcoidosis Vasculitis and Diffuse Lung Diseases (abbr: SARCOIDOSIS VASC DIF, ISSN: 1124-0490) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mattioli 1885 S.p.A. in Italy since 1996. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.500 (Q3), an H-index of 68.

The journal enforces rigorous peer evaluation with a publication frequency of Tri-annual, an annual output of approximately 41 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,854 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.